Hormone-positive Breast Cancer

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Hormone-positive Breast Cancer

Mar 23, 2025, 15:21 | Drugs

Elacestrant: What patients need to know?

Elacestrant (brand name Orserdu) is a breakthrough oral medication for treating advanced or metastatic estrogen…

Mar 23, 2025, 14:33 | Drugs

Elacestrant (Orserdu): Uses in Cancer: Side effects: Dosage: Expectations, and More

Elacestrant is an oral selective estrogen receptor degrader (SERD) used to treat advanced or metastatic…

Mar 11, 2025, 16:02 | Oncolibrary

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

Phase 3 VERITAC-2 trial (NCT05654623) results were announced by Arvinas and Pfizer. evaluating vepdegestrant, an…

Oct 10, 2024, 06:41 | Insight

Sami Mansfield: Is Soy Safe for Hormone-Positive Breast Cancer Survivors?

Sami Mansfield recently shared an article in AICR. Read her post on LinkedIn below: "Is…

All: 4 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023